ArticleBMC cancer2025

Targeting INF2 with DiosMetin 7-O-β-D-Glucuronide: a new stratagem for colorectal cancer therapy.

Zhirui Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.